TuHURA Biosciences Statistics
Total Valuation
HURA has a market cap or net worth of $135.42 million. The enterprise value is $132.50 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HURA has 63.58 million shares outstanding. The number of shares has increased by 156.81% in one year.
| Current Share Class | 63.58M |
| Shares Outstanding | 63.58M |
| Shares Change (YoY) | +156.81% |
| Shares Change (QoQ) | +4.61% |
| Owned by Insiders (%) | 33.74% |
| Owned by Institutions (%) | 10.18% |
| Float | 41.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.12 |
| P/TBV Ratio | 13.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.03.
| Current Ratio | 0.78 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.97 |
Financial Efficiency
Return on equity (ROE) is -169.18% and return on invested capital (ROIC) is -96.48%.
| Return on Equity (ROE) | -169.18% |
| Return on Assets (ROA) | -74.27% |
| Return on Invested Capital (ROIC) | -96.48% |
| Return on Capital Employed (ROCE) | -131.18% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.37M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -48.05% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 1.95 |
| Relative Strength Index (RSI) | 46.87 |
| Average Volume (20 Days) | 1,427,171 |
Short Selling Information
The latest short interest is 8.32 million, so 13.08% of the outstanding shares have been sold short.
| Short Interest | 8.32M |
| Short Previous Month | 7.49M |
| Short % of Shares Out | 13.08% |
| Short % of Float | 20.17% |
| Short Ratio (days to cover) | 7.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.12M |
| Pretax Income | -30.05M |
| Net Income | -30.06M |
| EBITDA | -28.05M |
| EBIT | -28.12M |
| Earnings Per Share (EPS) | -$0.63 |
Full Income StatementBalance Sheet
The company has $3.62 million in cash and $700,022 in debt, giving a net cash position of $2.92 million or $0.05 per share.
| Cash & Cash Equivalents | 3.62M |
| Total Debt | 700,022 |
| Net Cash | 2.92M |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 20.93M |
| Book Value Per Share | 0.35 |
| Working Capital | -1.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$27.63 million and capital expenditures -$76,083, giving a free cash flow of -$27.71 million.
| Operating Cash Flow | -27.63M |
| Capital Expenditures | -76,083 |
| Depreciation & Amortization | 71,265 |
| Net Borrowing | 616,976 |
| Free Cash Flow | -27.71M |
| FCF Per Share | -$0.44 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |